Coral Laboratories Limited (BOM:524506)

India · Delayed Price · Currency is INR

498.00

+3.15 (0.64%)

At close: Nov 6, 2026

Market Cap	1.78B +0.7%
Revenue (ttm)	967.01M -5.4%
Net Income	192.05M +7.2%
EPS	53.75 +7.2%
Shares Out	3.57M
PE Ratio	9.27
Forward PE	n/a
Dividend	2.00 (0.40%)
Ex-Dividend Date	Sep 22, 2026

Volume	338
Open	499.80
Previous Close	494.85
Day's Range	478.00 - 504.00
52-Week Range	360.00 - 679.00
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations

Founded 1994

Employees 149

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524506

Full Company Profile

Financial Performance

In fiscal year 2026, Coral Laboratories's revenue was 859.00 million, a decrease of -25.31% compared to the previous year's 1.15 billion. Earnings were 163.81 million, a decrease of -32.18%.

Financial Statements